glp-1 and sex SMSNA Will GLP-1 Medications Affect My

Disclosure of safety information in foreign countries The GLP-1 receptor agonist used for this treatment has been approved for the indication of obesity by the FDA in the United States, the MFDS in South Korea, and the EMA in EU27 countries

10.3892/etm.2018.6043 36 WuX.LiS.XueP.LiY

In the clinical trials, he added, We did find that a couple of our patients reported suicidal ideation, but it seemed to be related to life events occurring. However, Grunvald pointed out that semaglutide trials excluded patients with history of suicidal behavior, so they may be underestimating the risk. Still, the trials showed far lower rates of suicidal thoughts or behaviors than reported in the overall U.S

Lastly, we lacked information about patient compliance with prescribed treatments, which could have influenced our results

This hormone plays a crucial role in regulating your blood sugar levels, appetite, and digestion